Policy

ARPA-H is officially established. Now what?
ARPA-H is officially established. Now what?
Lecia Bushak
June 6, 2022
12:23 pm

Biden’s new life sciences agency faces questions over funding, scope and more.

Senate unveils user fee reauthorization draft, leaves out accelerated approval reform
Senate unveils user fee reauthorization draft, leaves out accelerated approval reform
Lecia Bushak
May 19, 2022
2:59 pm

User fees have historically been used to bolster the FDA’s work in reviewing the safety and efficacy of drugs, and must be renewed every five years.

The public health infrastructure debacle, revisited
The public health infrastructure debacle, revisited
Lecia Bushak
May 12, 2022
2:59 pm

As Congress struggles to secure more pandemic aid, experts are once again calling for long-term investment in public health infrastructure. Will anyone listen?

Inside the FDA/McKinsey divorce
Inside the FDA/McKinsey divorce
Lecia Bushak
May 5, 2022
1:00 pm

The agency is severing ties with McKinsey in the wake of conflict-of-interest concerns around the consultancy’s work with opioid makers.

Can the CDC’s internal review staunch the credibility and comms bleeding?
Can the CDC’s internal review staunch the credibility and comms bleeding?
Lecia Bushak
April 7, 2022
11:23 am

The agency has acknowledged that it has a problem. Now comes the hard part.

Not so fast: Health experts call for preservation of COVID testing infrastructure
Not so fast: Health experts call for preservation of COVID testing infrastructure
Lecia Bushak
March 31, 2022
3:42 pm

Even as funding for federal efforts remains in limbo, there’s plenty of optimism about the future of diagnostic testing – for COVID-19 and for other conditions.

Is there a coherent plan for public health data infrastructure?
Is there a coherent plan for public health data infrastructure?
Lecia Bushak
March 23, 2022
4:42 pm

More than two years into the pandemic, the long-needed data modernization push remains dormant.

Debate over accelerated approval emerges in Congress
Debate over accelerated approval emerges in Congress
Lecia Bushak
March 18, 2022
4:37 pm

Support for limiting drugmakers’ use of the regulatory pathway, or facilitating it, is split along party lines.

COVID funding was dropped from the government funding bill. Now what?
COVID funding was dropped from the government funding bill. Now what?
Lecia Bushak
March 11, 2022
10:33 am

In the wake of the decision to pull the emergency aid package, experts are continuing to call for more consistent federal public health investment.

Lawmakers tackle mental health, finally
Lawmakers tackle mental health, finally
Lecia Bushak
February 28, 2022
11:51 am

With drug pricing reform in limbo, lawmakers are pushing for stricter enforcement of mental health parity laws.

  • From Our Partners